Sachem Capital Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Sachem Capital Corp. on December 7, 2021, reporting events occurring on December 6, 2021. The Company is a business development company incorporated in New York with its principal executive office in Branford, Connecticut.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity metrics. It is a disclosure of a material definitive agreement rather than a periodic financial report.
Material Changes and Agreements
On December 6, 2021, the Company entered into an At Market Issuance Sales Agreement (the "Sales Agreement") with Ladenburg Thalmann & Co., Inc. and Janney Montgomery Scott LLC, acting as distribution agents. Key terms include:
- Offering Capacity: The Company may offer and sell up to $44,925,000 of its common shares (Placement Shares) through the agents.
- Method: Sales will be conducted via "at the market offerings" as defined in Rule 415 under the Securities Act of 1933.
- Compensation: The Company will pay the agents commissions, discounts, or other compensation of up to 2.0% on the gross proceeds from the sale of Placement Shares.
- Obligation: The Company has no obligation to sell any shares under this agreement.
- Registration: The offering is pursuant to a prospectus supplement dated December 6, 2021, filed under an effective Registration Statement on Form S-3 (File No. 333-256940).
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance or management commentary on future performance. The primary risk disclosed relates to the potential dilution of existing shareholders if the Company elects to sell shares under the Sales Agreement. The agreement includes customary indemnification provisions where the Company agrees to indemnify the agents against certain liabilities under the Securities Act.
Investor Verification Checklist
- Verify the current market price of Sachem Capital Corp. common shares to assess potential dilution impact.
- Review the full text of the At Market Issuance Sales Agreement (Exhibit 1.1) for specific termination rights and conditions.
- Monitor subsequent filings to determine if and when the Company elects to sell shares under this agreement.
- Check the Company's most recent 10-Q or 10-K for actual liquidity and debt positions, as this 8-K does not provide them.